TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ZYME

Zymeworks Inc.

Healthcare · Biotechnology

26.80$ +0.9% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow ZYME
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-420.1% -229.5% -320.2% 0.4% 45.6% -277.1% -388.7% -721.3% 34.9% -155.6% -144.2% -31.1%
24.7% 5.1% 9.3% 5.3% 6.8% 24.8% 26.4% 35.9% 2.9% 22.8% 14.7% 10.2%
34.4% 14.4% 39.0% 6.6% 25.4% 165.8% 74.8% 40.3% 1.0% 10.7% 23.3% 26.5%
51.9% 14.5% -0.9% 11.8% 32.0% 167.7% 74.3% 34.5% 0.9%
278.3% -50.7% -21.5% 3.4% 75.3% 21.8% -26.1% 1.5% 1.0% -33.6% -40.6% 7.1%
16.8% 8.8% 49.6% 6.0% 6.5% 47.0% 16.1% 49.8% 3.2% 5.4% 4.0% 1.4%
-16.8% -95.2% -231.2% -59.7% -205.7% -86.6% -111.5% 542.0% -13.1% -272.7% 50.8% 25.2%
2.0% 2.9% 1,071.1%
2,802.3% 19.5% 534.8% 111.6% 172.5% 2.0% 2.9% 7.8% 0.3% 1,078.8% -39.4% -39.3%
-0.5% 0.0% 63.1% -15.1% 0.0% -0.1% -0.1% -0.1% 0.0% 0.0% 0.0%
2,777.7% 15.7% 588.4% 96.5% 172.4% 655.5% 793.2% 30.0% 26.3% 107.7% -26.8% -17.5%
2,266.2% -365.6% 44.7% 37.7% 11.8% 291.9% 291.6% -150.6% 48.3% -320.2% -119.9% -23.5%
-436.9% -238.3% -369.8% -5.6% 39.2% -324.0% -404.8% -771.1% 31.8% -161.0% -148.2% -32.6%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?